Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$135.68 - $176.11 $854,784 - $1.11 Million
6,300 Added 81.82%
14,000 $2.2 Million
Q2 2024

Aug 14, 2024

BUY
$72.62 - $150.62 $152,502 - $316,302
2,100 Added 37.5%
7,700 $1.16 Million
Q1 2024

May 15, 2024

SELL
$70.86 - $89.93 $106,290 - $134,895
-1,500 Reduced 21.13%
5,600 $414,000
Q4 2023

Feb 14, 2024

BUY
$36.74 - $81.08 $260,854 - $575,668
7,100 New
7,100 $560,000
Q1 2022

May 16, 2022

SELL
$12.58 - $26.94 $205,054 - $439,122
-16,300 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$19.16 - $32.68 $28,740 - $49,020
-1,500 Reduced 8.43%
16,300 $317,000
Q3 2021

Nov 12, 2021

BUY
$25.92 - $34.51 $54,432 - $72,471
2,100 Added 13.38%
17,800 $566,000
Q2 2021

Aug 06, 2021

BUY
$21.63 - $40.07 $339,591 - $629,099
15,700 New
15,700 $517,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.24B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.